Skip to main content
. 2018 Feb 2;18(7):1735–1744. doi: 10.1111/ajt.14642

Table 1.

Descriptive patient data collected prior to transplantation

Parameter Patient 1 Patient 2 Patient 3 Patient 4
Gender Female Male Male Female
Age (years) 53 47 59 44
Weight (kg) 72 99 79 72
Height (cm) 174 189 179 172
BMI (kg/m2) 23.8 27.7 24.7 24.3
Diabetes duration (years) 41 30 30 39
Retinopathy Discrete Discrete Discrete Discrete
Treatment regimen Injections Pump Pump Injections
HbA1c before run‐in (mmol/mol, DCCT %) 73 (8.8) 68 (8.4) 66 (8.2) 63 (7.9)
HbA1c after run‐in (mmol/mol, DCCT %) 62 (7.8) 71 (8.6) 62 (7.8) 63 (7.9)
Total insulin doses (U/24 h) 36 54 46 30
Insulin doses (U/24 h/kg) 0.5 0.56 0.58 0.42
Exercise 3 times weekly 2‐3 times weekly 2‐3 times weekly 2‐3 times weekly
Hypoglycemia unawareness No No No No
Other drugs Levothyroxine Statins Levothyroxine
Total number of islets (IEQ) transplanted and islet purity (%) 155 000
96%
180 000
81%
180 000, 180 000
86%, 89%
180 000
92%
Number of islets transplanted (IEQ/kg BW) 2150 1800 4600 2500

Apart from discrete retinopathy none of the patients had any diabetes‐related long‐term complications. IEQ, islet equivalents.